Why POET Technologies Stock Keeps Falling

POET Technologies fell 7.3% on Friday and is down roughly 40% from its mid-May peak after Marvell’s AI division canceled all purchase orders with the company. The stock also faces added dilution from a $400 million registered direct offering that issued about 19 million new shares plus warrants, while multiple class actions and a P/S ratio above 1,000 keep pressure on valuation and sentiment. The combination of lost business, dilution, and litigation makes the setup materially negative for shareholders.

Analysis

The market is not just marking down POET’s operating outlook; it is repricing the equity as a financing instrument with a distressed customer concentration problem. Once a strategic counterparty publicly terminates purchase orders, every remaining commercial discussion becomes more asymmetric for the buyer, because POET loses pricing leverage while customers gain optionality to wait for lower entry points or alternative suppliers. That dynamic matters more than the headline revenue hit: it increases the probability that any future growth comes with worse gross margin quality and more dilution.

The offering is the bigger second-order blow. A large equity raise after a customer loss telegraphs that the company needed liquidity before the business could prove durable self-funding, which compresses the equity IRR even if execution improves. In names like this, the post-raise supply overhang usually persists for weeks to months, especially when litigation risk is added; that combination tends to cap rebounds on any positive news because incremental buyers know they are effectively backstopping a series of future financings.

Competitively, the fallout is more likely to help larger optical/AI interconnect vendors than peers of similar size. Buyers of advanced photonics infrastructure will prefer vendors with diversified customer bases, stronger balance sheets, and fewer headline risks, which should modestly support incumbent adoption against smaller challengers. MRVL is only a partial read-through, but the order cancellation suggests its AI group is pruning vendor experiments, a negative signal for adjacent early-stage suppliers that depended on “design-win optionality” rather than locked demand.

The contrarian case is that the stock may not be as mechanically broken as the narrative implies if management can quickly replace the lost orders and stabilize cash burn. But with valuation still detached from fundamental reality, any bounce is likely tradeable rather than investable unless there is a verified reset in backlog, cash runway, and customer diversification. Until then, the path of least resistance remains lower because sentiment, dilution, and legal overhangs are all moving in the same direction.

Key Decisions for Investors

• Avoid long exposure to POET for the next 4-8 weeks; the likely catalyst path is more downward than upward as dilution overhang and litigation headlines are digested.
• If shortable, initiate a tactical short in POET on strength or via rallies back toward prior support, targeting a 15-25% downside window with a tight cover discipline above any confirmed customer-replacement announcement.
• Pair trade: long diversified AI infrastructure leader exposure vs. short POET as a basket hedge against photonics supply-chain optimism; use the spread to express relative quality rather than outright sector beta.
• For event-driven accounts, buy short-dated put spreads in POET into any volatility spike; the structure benefits from further de-rating while capping premium at risk if management delivers a surprise contract update.
• Watch MRVL for broader supplier-risk sentiment, but do not chase it short absent additional evidence; the cleaner opportunity is to fade weaker small-cap AI hardware names that trade on narrative rather than backlog quality.